Cancer, inflammation and the AT1 and AT2 receptors
Open Access
- 1 January 2004
- journal article
- Published by Springer Nature in Journal of Inflammation
- Vol. 1 (1), 3
- https://doi.org/10.1186/1476-9255-1-3
Abstract
The critical role of inappropriate inflammation is becoming accepted in many diseases that affect man, including cardiovascular diseases, inflammatory and autoimmune disorders, neurodegenerative conditions, infection and cancer.Keywords
This publication has 82 references indexed in Scilit:
- Immune responses in cancerPharmacology & Therapeutics, 2003
- Interleukin-1—a major pleiotropic cytokine in tumor–host interactionsSeminars in Cancer Biology, 2002
- Transforming growth factor-β-induced transcription of the Alzheimer β-amyloid precursor protein gene involves interaction between the CTCF-complex and SmadsBiochemical and Biophysical Research Communications, 2002
- Human Papillomavirus in LarynxThe Laryngoscope, 2002
- Differences between Squamous Cell Carcinoma and Keratoacanthoma in Angiotensin Type-1 Receptor ExpressionThe American Journal of Pathology, 2001
- The Hallmarks of CancerCell, 2000
- Preactivated Peripheral Blood Monocytes in Patients With Essential HypertensionHypertension, 1999
- Effects of growth factors on cell proliferation and angiotensin II type 2 receptor number and mRNA in PC12W and R3T3 cellsMolecular and Cellular Endocrinology, 1998
- AT1 angiotensin II receptor subtype in the human larynx and squamous laryngeal carcinomaCancer Letters, 1996
- Angiotensin II elevates cytosolic free calcium in human lung adenocarcinoma cells via activation of AT1 receptorsCancer Letters, 1994